Literature DB >> 8342283

Future directions in sickle cell disease.

A Anand.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8342283      PMCID： PMC1022151     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  5 in total

Review 1.  Future prospects for treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos
Journal:  West J Med       Date:  1992-12

2.  Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis.

Authors:  T Teuscher; C W Von Der Ahe; P Baillod; B Holzer
Journal:  Trop Geogr Med       Date:  1989-10

3.  Is there a role for selective vasodilation in the management of sickle cell disease?

Authors:  G P Rodgers; M S Roy; C T Noguchi; A N Schechter
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

4.  Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.

Authors:  L R Berkowitz; E P Orringer
Journal:  Blood Cells       Date:  1982

5.  A collaborative, double-blind randomized study of cetiedil citrate in sickle cell crisis.

Authors:  L J Benjamin; L R Berkowitz; E Orringer; V N Mankad; A S Prasad; L M Lewkow; R K Chillar; C M Peterson
Journal:  Blood       Date:  1986-05       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.